{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T13:27:16Z","timestamp":1773581236159,"version":"3.50.1"},"reference-count":28,"publisher":"AVES YAYINCILIK A.\u015e.","issue":"4","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Rheumatology"],"abstract":"<jats:p>Objectives: The study aimed to describe the prevalence and patterns of pulmonary lesions in the patients with psoriatic arthritis (PsA).\r\nPatients and methods: Pulmonary symptoms and thorax imaging findings of 247 patients (155 females, 92 males, mean age: 52.0\u00b112.6 years; range, 23 to 87 years) with PsA diagnosed according to CASPAR (Classification Criteria for Psoriatic Arthritis) diagnostic criteria were retrospectively reviewed between January 01, 2014 and December 31, 2020. Thoracic computed tomography or high-resolution computed tomography, whichever was accessible, was used as the imaging method.\r\nResults: Thoracic imaging revealed at least one pulmonary lesion in 25 (10.1%) patients. The frequency of interstitial lung diseases (ILD) was 3.6% (n=9) in the PsA cohort. Other commonly detected pulmonary lesions were pulmonary nodules (n=21, 8.5%) and airway abnormalities (n=15, 6.1%; eight emphysema and seven bronchitis). ILD patterns were nonspecific interstitial pneumonia in three (1.2%) patients, cryptogenic organizing pneumonia in two (0.8%) patients, and probable usual interstitial pneumonia in two (0.8%) patients. ILD patterns in two (0.8%) patients could not be categorized and accepted as unclassifiable type. None of the patients had apical fibrosis. The mean age was higher in patients with ILD (p=0.007), and ILD was found to be more common in males (p=0.010), current or former smokers (p=0.012), and patients receiving hydroxychloroquine treatment (p=0.028).\r\nConclusion: The frequency and severity of ILD in the patients with PsA was lower than those reported in connective tissue diseases. Apical fibrosis, which may be present in ankylosing spondylitis, another member of the spondyloarthritis group, was not detected.<\/jats:p>","DOI":"10.46497\/archrheumatol.2024.10537","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:56:27Z","timestamp":1740988587000},"page":"631-640","source":"Crossref","is-referenced-by-count":3,"title":["Lung involvement in patients with psoriatic arthritis"],"prefix":"10.5152","volume":"39","author":[{"family":"Mehmet H\u00fcn\u00fcr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Tahir Sayg\u0131n \u00d6\u011f\u00fct","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ece \u00c7elik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Funda Erbasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Melis Dilbil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mine Nokay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mustafa Ender Terzio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Veli Yazisiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3111","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Dal Bello G, Gisondi P, Idolazzi L, Girolomoni G. Psoriatic arthritis and diabetes mellitus: A narrative review. Rheumatol Ther 2020;7:271-85. doi: 10.1007\/ s40744-020-00206-7.","DOI":"10.1007\/s40744-020-00206-7"},{"key":"ref-2","unstructured":"Gladman DD, Ritchlin C. Clinical manifestations and diagnosis of psoriatic arthritis. 2010:v18. Available at: https:\/\/www.uptodate.com\/contents\/clinicalmanifestations-and-diagnosis-of-psoriatic-arthritis."},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, et al. A patient-derived and patientreported outcome measure for assessing psoriatic arthritis: Elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 2014;73:1012-9. doi: 10.1136\/ annrheumdis-2014-205207.","DOI":"10.1136\/annrheumdis-2014-205207"},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Wang J, Ke R, Shi W, Yan X, Wang Q, Zhang Q, et al. Association between psoriasis and asthma risk: A meta-analysis. Allergy Asthma Proc 2018;39:103-9. doi: 10.2500\/aap.2018.39.4109.","DOI":"10.2500\/aap.2018.39.4109"},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Malerba M, Ponticiello A, Radaeli A, Bensi G, Grassi V. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial). Pulm Pharmacol Ther 2004;17:27-34. doi: 10.1016\/j. pupt.2003.08.004.","DOI":"10.1016\/j.pupt.2003.08.004"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Dejcman D, Skowasch D, Pizarro C, Krause A, Thomas D, Sch\u00e4fer VS. Pulmonary manifestations of rheumatoid arthritis, psoriatic arthritis and peripheral spondyloarthritis: Prevalence, diagnostic approach and treatment options. Curr Rheumatol Rev 2021;17:17-28. doi: 10.2174\/157339711666620090 5122757.","DOI":"10.2174\/1573397116666200905122757"},{"key":"ref-7","unstructured":"Webb WR, Muller NL, Naidich DP. High-resolution CT of the lung. Philadelphia: Lippincott Williams & Wilkins; 2014."},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"McGonagle DG, McInnes IB, Kirkham BW, Sherlock J, Moots R. The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: Recent advances and controversies. Ann Rheum Dis 2019;78:1167-78. doi: 10.1136\/annrheumdis-2019-215356.","DOI":"10.1136\/annrheumdis-2019-215356"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Demoruelle MK, Mittoo S, Solomon JJ. Connective tissue disease-related interstitial lung disease. Best Pract Res Clin Rheumatol 2016;30:39-52. doi: 10.1016\/j.berh.2016.04.006.","DOI":"10.1016\/j.berh.2016.04.006"},{"key":"ref-10","unstructured":"Fagan NL, Foral PA, Malesker MA, Morrow LE. Therapeutic update on drug-induced pulmonary disorders. 2011 [Internet]. Available at: https:\/\/www. uspharmacist.com\/article\/therapeutic-update-ondrug-induced-pulmonary-disorders."},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Ishikawa G, Dua S, Mathur A, Acquah SO, Salvatore M, Beasley MB, et al. Concomitant interstitial lung disease with psoriasis. Can Respir J 2019;2019:5919304. doi: 10.1155\/2019\/5919304.","DOI":"10.1155\/2019\/5919304"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"Peluso R, Iervolino S, Vitiello M, Bruner V, Lupoli G, Di Minno MN. Extra-articular manifestations in psoriatic arthritis patients. Clin Rheumatol 2015;34:745-53. doi: 10.1007\/s10067-014-2652-9.","DOI":"10.1007\/s10067-014-2652-9"},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Kanathur N, Lee-Chiong T. Pulmonary manifestations of ankylosing spondylitis. Clin Chest Med 2010;31:547- 54. doi: 10.1016\/j.ccm.2010.05.002.","DOI":"10.1016\/j.ccm.2010.05.002"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Manuel A, Jones Q, Wiggins J. Multiple pulmonary nodules in a male with psoriatic arthritis. Eur Respir Rev 2010;19:164-5. doi: 10.1183\/09059180.00001210.","DOI":"10.1183\/09059180.00001210"},{"key":"ref-15","unstructured":"Scarpa R, Cosentini E, Manguso F, Oriente A, Peluso R, Atteno M, et al. Clinical and genetic aspects of psoriatic arthritis \"sine psoriasis\". J Rheumatol 2003;30:2638-40."},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, et al. An official European Respiratory Society\/American Thoracic Society research statement: Interstitial pneumonia with autoimmune features. Eur Respir J 2015;46:976-87. doi: 10.1183\/13993003.00150-2015.","DOI":"10.1183\/13993003.00150-2015"},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"Oke JL, Pickup LC, Declerck J, Callister ME, Baldwin D, Gustafson J, et al. Development and validation of clinical prediction models to risk stratify patients presenting with small pulmonary nodules: A research protocol. Diagn Progn Res 2018;2:22. doi: 10.1186\/ s41512-018-0044-3.","DOI":"10.1186\/s41512-018-0044-3"},{"key":"ref-18","doi-asserted-by":"crossref","unstructured":"Mazzone PJ, Lam L. Evaluating the patient with a pulmonary nodule: A review. JAMA 2022;327:264- 73. doi: 10.1001\/jama.2021.24287.","DOI":"10.1001\/jama.2021.24287"},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"El Maghraoui A, Dehhaoui M. Prevalence and characteristics of lung involvement on high resolution computed tomography in patients with ankylosing spondylitis: A systematic review. Pulm Med 2012;2012:965956. doi: 10.1155\/2012\/965956.","DOI":"10.1155\/2012\/965956"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"Yoo H, Hino T, Han J, Franks TJ, Im Y, Hatabu H, Chung MP, Lee KS. Connective Tissue Diseaserelated Interstitial Lung Disease (CTD-ILD) and Interstitial Lung Abnormality (ILA): Evolving concept of CT findings, pathology and management. Eur J Radiol Open 2020;8:100311. doi: 10.1016\/j. ejro.2020.100311.","DOI":"10.1016\/j.ejro.2020.100311"},{"key":"ref-21","doi-asserted-by":"crossref","unstructured":"Bargagli E, Bellisai F, Mazzei MA, Conticini E, Alderighi L, Cameli P, et al. Interstitial lung disease associated with psoriatic arthritis: a new disease entity? Intern Emerg Med 2021;16:229-31. doi: 10.1007\/s11739-020-02451-8.","DOI":"10.1007\/s11739-020-02451-8"},{"key":"ref-22","doi-asserted-by":"crossref","unstructured":"Demoruelle MK, Mittoo S, Solomon JJ. Connective tissue disease-related interstitial lung disease. Best Pract Res Clin Rheumatol 2016;30:39-52. doi: 10.1016\/j.berh.2016.04.006.","DOI":"10.1016\/j.berh.2016.04.006"},{"key":"ref-23","doi-asserted-by":"crossref","unstructured":"Micheletti RG, Pagnoux C. Management of cutaneous vasculitis. Presse Med 2020;49:104033. doi: 10.1016\/j.lpm.2020.104033.","DOI":"10.1016\/j.lpm.2020.104033"},{"key":"ref-24","doi-asserted-by":"crossref","unstructured":"Ahmed S, Handa R. Management of connective tissue disease-related interstitial lung disease. Curr Pulmonol Rep 2022;11:86-98. doi: 10.1007\/s13665- 022-00290-w.","DOI":"10.1007\/s13665-022-00290-w"},{"key":"ref-25","doi-asserted-by":"crossref","unstructured":"Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB, et al. Lung involvement in patients with primary Sj\u00f6gren's syndrome: What are the predictors? Rheumatol Int 2010;30:1317-24. doi: 10.1007\/ s00296-009-1152-8.","DOI":"10.1007\/s00296-009-1152-8"},{"key":"ref-26","doi-asserted-by":"crossref","unstructured":"Yazisiz V, G\u00f6\u00e7er M, Erbasan F, U\u00e7ar \u0130, Aslan B, Oygen \u015e, et al. Survival analysis of patients with Sj\u00f6gren's syndrome in Turkey: A tertiary hospital-based study. Clin Rheumatol 2020;39:233-41. doi: 10.1007\/ s10067-019-04744-6.","DOI":"10.1007\/s10067-019-04744-6"},{"key":"ref-27","doi-asserted-by":"crossref","unstructured":"Griese M, K\u00f6hler M, Witt S, Sebah D, Kappler M, Wetzke M, et al. Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial. Trials 2020;21:307. doi: 10.1186\/s13063-020-4188-4.","DOI":"10.1186\/s13063-020-4188-4"},{"key":"ref-28","doi-asserted-by":"crossref","unstructured":"Poddubnyy D, Jadon DR, Van den Bosch F, Mease PJ, Gladman DD. Axial involvement in psoriatic arthritis: An update for rheumatologists. Semin Arthritis Rheum 2021;51:880-7. doi: 10.1016\/j. semarthrit.2021.06.006.","DOI":"10.1016\/j.semarthrit.2021.06.006"}],"container-title":["Archives of Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1456\/2604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1456\/2605","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1456\/2604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:00:41Z","timestamp":1761210041000},"score":1,"resource":{"primary":{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/view\/1456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,31]]}},"URL":"https:\/\/doi.org\/10.46497\/archrheumatol.2024.10537","relation":{},"ISSN":["2618-6500"],"issn-type":[{"value":"2618-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}